We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Why I’d buy this FTSE 100 dividend growth stock and never sell

I think temporary weakness could be an opportunity with this attractive FTSE 100 (INDEXFTSE: UKX) share.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

There aren’t many London-listed shares I can honestly say I’d buy and never sell, but health and home hygiene consumer goods manufacturer Reckitt Benckiser Group (LSE: RB) is one of them.

This year, the firm restructured into two divisions, Health and Hygiene Home, after acquiring Mead Johnson Nutrition Company during 2017. Today’s third-quarter results report sent the shares lower, though, despite the headline that the firm is “On track for full-year targets.” Like-for-like growth in the quarter came in at 2% compared to the equivalent period last year, but overall growth took a 2% hit – down by £70m – because of a temporary manufacturing disruption” at the firm’s European infant nutrition plant.

Should you buy Reckitt Benckiser Group Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Moody Mr Market

I’m not surprised that the stock market has focused on the negative today. It’s the same story everywhere – good news is practically ignored and the slightest whiff of something less than positive and the market piles in for its over-generous pound of flesh by thumping share prices down. This market will have its correction, make no mistake about that!

Yet I’d suggest that market weakness is what you want if you are a buyer of shares to hold for the long haul. If you are in the business of accumulating shares rather than selling them, you want share prices and valuations to be as low as possible so that you get more for your money. Then, ideally, you want a great big speculative bubble that pushes shares and valuations as high as possible just before you sell, such as when you retire, maybe.

So I see today’s weakness in the share price as an opportunity for me to buy. The company said in the report that it is on track to meet its target and increase revenues by 14% to 15% of which like-for-like revenues should achieve a 2% to 3% increase. I reckon it is important to see growing revenues because profits can only keep on rising if the top line keeps growing as well. Sometimes firms make efficiency and cost savings that drive profits up while revenue remains static, but that kind of growth in profits can only go so far.

Strong brands shining through

Chief executive Rakesh Kapoor said in the report that the base Health and Hygiene Home businesses achieved 4% like-for-like growth in the quarter “against a backdrop of mixed market conditions.” He puts this down to the strength of the firm’s brands, innovation success and “early signs” of benefits from the recent restructuring.

Indeed, there’s a lot to like about Reckitt Benckiser and I reckon the firm still retains its ‘defensive’ characteristics, despite the recent volatility in the share price. The consumer goods space retains its attractions and we can see the benefits of being in the business in the company’s financial record – over several years there’s been steady growth in revenue, earnings, cash inflow and the dividend. The cash flowing into the business supports those escalating earnings well.

To me, Reckitt Benckiser would make a decent core holding in any long-term-focused portfolio and I think the stock is well worth your attention now.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female couple boarding their plane at the airport to go on holiday.
Investing Articles

Can the Rolls-Royce share price reach £15.97 by the end of August?

The Rolls-Royce share price has had a solid run in the last year. Muhammad Cheema takes a look at whether…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Up 1,200% in 5 years, here’s why Nvidia could still be a brilliant value stock

An exciting new announcement that could reshape the PC industry has just pushed Nvidia stock... well, just about nowhere really.

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

How investing £4.50 a day could set you on the way to a £1,505 monthly second income

How can UK stocks with high dividend yields help investors earn a meaningful second income from the price of a…

Read more »

Investing Articles

Up 103% with a P/E of 261 — is this FTSE 100 stock still worth buying?

One FTSE 100 stock is quietly moving higher while most investors are still looking elsewhere — is the market missing…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

The smart money thinks AI stocks look risky — but is there still a chance to buy?

According to fund managers, the AI trade is getting crowded. But they still seem to think it’s the place to…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Barclays shares are 11% below their 52-week high. Could they be a bit of a bargain to consider?

Overpriced or one of the FTSE 100’s hidden gems? James Beard takes a closer look at how the market is…

Read more »

Stack of one pound coins falling over
Investing Articles

Down 65% but yielding 6.7% – is this beaten-down UK stock now a generational bargain?

Harvey Jones says this UK stock is one of the worst FTSE 100 performers but there are sound reasons to…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Is this FTSE stock really 46% undervalued?

Analysts reckon this FTSE stock should be worth nearly 50% more. James Beard considers why there’s so much positivity surrounding…

Read more »